Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses.
Omedè P, Tarella C, Palumbo A, Argentino C, Caracciolo D, Corradini P, Dominietto A, Giaretta F, Ravaglia R, Triolo R, Triolo S, Pileri A, Boccadoro M. Omedè P, et al. Among authors: giaretta f. Br J Haematol. 1997 Dec;99(3):685-91. doi: 10.1046/j.1365-2141.1997.4493259.x. Br J Haematol. 1997. PMID: 9401085 Free article.
Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphoma.
Zallio F, Cuttica A, Caracciolo D, Gavarotti P, Bergui L, Giaretta F, Bondesan P, Tassi V, Gallo E, Pileri A, Tarella C. Zallio F, et al. Among authors: giaretta f. Ann Hematol. 2002 Aug;81(8):448-53. doi: 10.1007/s00277-002-0492-1. Epub 2002 Aug 2. Ann Hematol. 2002. PMID: 12224002 Clinical Trial.
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions.
Tarella C, Corradini P, Astolfi M, Bondesan P, Caracciolo D, Cherasco C, Ladetto M, Giaretta F, Ricca I, Vitolo U, Pileri A, Ferrero D. Tarella C, et al. Among authors: giaretta f. Leukemia. 1999 Sep;13(9):1456-62. doi: 10.1038/sj.leu.2401488. Leukemia. 1999. PMID: 10482999 Clinical Trial.
Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcome.
Tarella C, Castellino C, Cherasco C, Bondesan P, Giaretta F, Corradini P, Caracciolo D, Gavarotti P, Pileri A. Tarella C, et al. Among authors: giaretta f. Br J Haematol. 1997 Oct;99(1):41-6. doi: 10.1046/j.1365-2141.1997.3433157.x. Br J Haematol. 1997. PMID: 9359500 Free article. Clinical Trial.
Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +- alpha-interferon.
Ferrero D, Foli C, Giaretta F, Argentino C, Rus C, Pileri A. Ferrero D, et al. Among authors: giaretta f. Leukemia. 2001 Mar;15(3):422-9. doi: 10.1038/sj.leu.2402038. Leukemia. 2001. PMID: 11237066
20 results